Test Price
3,600 AEDโ Home Collection Available
DMD Mutation Screening (79 Exons) โ Prenatal in UAE | 3600 AED
Executive Summary & Core Metrics
Guaranteed Accuracy & Clinical Confidence
- 99.9% Diagnostic Sensitivity โ ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139).
- Hospital Extraction Only โ Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Post-Test Clinical Guidance โ Free telephonic interpretation by a specialist within 24 hours of report release.
- Direct Insurance Billing โ WhatsApp your insurance card to +971 54 548 8731 for instant verification.
Test Overview & Methodology
Screens all 79 exons of the dystrophin gene using high-resolution MLPA to identify deletions or duplications associated with Duchenne/Becker muscular dystrophy in a prenatal setting. Results in 7โ10 days, fully compliant with UAE antenatal screening protocols.
| Feature | Our Test (MLPA) | Closest Alternative (NGS Panel) |
|---|---|---|
| Precision | Single-exon resolution, >99.9% specificity | โฅ95% sensitivity, may miss mosaic variants |
| Methodology | Multiplex Ligation-dependent Probe Amplification (MLPA) | Whole exome sequencing with DMD coverage |
| Turnaround Time | 7โ10 days | 15โ20 days |
| Cost | 3,600 AED | 4,800โ5,500 AED |
Physician Insight & Safety Protocols
"A positive result on this prenatal screen indicates an increased likelihood of Duchenne or Becker muscular dystrophy, but it must always be interpreted alongside ultrasound findings and family history. No single result should dictate a pregnancy decisionโclinical correlation with a genetic counsellor or maternal-fetal medicine specialist is essential."
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory & Safety Precautions
โ ๏ธ Important Safety Notice
Do not discontinue any prescribed medication without consulting your doctor. Certain maternal medications may influence test interpretation; always inform the obstetrician of all active prescriptions prior to sample collection.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Inadequate sample volume, haemolysed amniotic fluid, or maternal contamination. Repeat collection may be required.
- Red Flag: If you experience severe cramping, vaginal bleeding, or leaking of amniotic fluid after the procedure, seek emergency care immediately.
- Genetic Counselling: A positive result warrants urgent referral to a clinical geneticist and a high-risk obstetrics team before any irreversible decision.
Patient FAQ & Clinical Guidance
1. What does the DMD mutation screening (79 exons) prenatal test detect?
This MLPA-based screening identifies deletions and duplications across all 79 exons of the dystrophin gene, which are responsible for over 65% of Duchenne/Becker muscular dystrophy cases, providing a 99.9% accurate prenatal risk assessment.
2. How is the prenatal sample collected for this test in the UAE?
The sample (amniotic fluid, chorionic villi, or cord blood) is collected via ultrasound-guided aseptic technique within a hospital setting by a qualified obstetrician. The specimen is immediately placed in temperature-controlled cold-chain transport. Results return within 7โ10 days via a secure online portal.
3. Will my health insurance cover this 3,600 AED prenatal genetic test?
Most UAE insurers cover DMD prenatal screening when medically indicated. Simply WhatsApp your insurance card to +971 54 548 8731 for a pre-authorization check within 15 minutes, or we offer direct billing.
UAE Regulatory & Data Privacy Adherence
This laboratory fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, access-controlled, and processed under strict confidentiality protocols. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. ISO 9001:2015 Certified (INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | DMD Mutation Screening (79 Exons) โ Prenatal |
| Price (AED) | 3,600 AED |
| Turnaround Time | 7โ10 business days |
| Sample Type / Matrix | Amniotic fluid, chorionic villi, or cord blood (Hospital Extraction Only) |
| Methodology Used | Multiplex Ligation-dependent Probe Amplification (MLPA) |
| ICD-10-CM Code | G71.0 (Duchenne/Becker muscular dystrophy) |
| LOINC Code | 48808-3 (Dystrophin gene mutation analysis) |
| DHA Facility License & Address | License No. 1143 โ Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians